RCE

6.86%

54.5¢ recce pharmaceuticals ltd

Look at the upside... more tests mean more news flow... & that s...

First 30 Last

Share
Profile

Follow
TradingHault

1,550 Posts.

45

06/06/18

22:47

Post #: 33545899
Share

Originally posted by Pussycat1975 ↑

You guys are far too focused on human trials.

It is time you really looked at what is required by the FDA and also look at previous Recce announcements.

Before human trials can start Recce must have been granted Investigational New Drug Status (IND). Recce used to talk about this but have lately dropped any reference to IND.

To obtain IND the FDA needs to be sure that the drug “Recce 327” has been subject to appropriate testing.

Appropriate testing involves the testing of the drug to be performed under GLP standards. See previous announcements a long time ago re schedule of tests. Recently did identify GLP tests it was going to do.

To date Recce have not released any data about it performing tests under GLP standards.

Why? Perhaps because these tests are very expensive and take a long time. Also I think that due to the real concern around existing antibiotics becoming less effective Recce were hoping for the FDA to lower their standards.

Obviously the meeting with the FDA reinforced the requirements of the FDA I.e. Recce needs to perform GLP tests. The results of these GLP tests together with other relevant information regarding the chemical characteristics of the drug, the drug production methodology will be the basis for Recce applying for IND status.

If Recce are awarded IND status they can then think about human trials.

The recent announcement says it will be several quarters before Recce can really look at human trials.

I think this means that Recce were told by the FDA they have a lot more tests to do (GLP tests)

If Recce hade done all the required tests of the FDA it would not take several quarters to get to the next step.

I think Recce’s announcements have been very vague.

We shareholders deserve a more detailed explanation of what is really happening!!!

Expand

Look at the upside... more tests mean more news flow... & that s good news for the RCE holders. Back to the Lab boys!

Last edited by TradingHault: 06/06/18

RCE Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

As Nvidia cools, we're looking to Aussie AI

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

CBA breaks trading record on strong day for Aussie financials

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

There are more pages in this discussion • 11 more messages in this thread...

First 30 Last

Add RCE (ASX) to my watchlist

(20min delay)
Last 54.5¢		Change 0.035(6.86%)		Mkt cap ! $126.2M

Open	High	Low	Value	Volume
51.0¢	55.0¢	51.0¢	$167.8K	316.5K

Buyers (Bids)

No.	Vol.	Price($)
1	317	53.5¢

Sellers (Offers)

Price($)	Vol.	No.
54.5¢	4099	2

View Market Depth

No.	Vol.	Price($)
1	317	0.535
1	4000	0.530
2	35000	0.525
1	12500	0.520
1	25000	0.515

Price($)	Vol.	No.
0.545	45	1
0.550	5054	2
0.555	10000	1
0.560	6785	3
0.570	44444	1

Last trade - 15.59pm 06/09/2024 (20 minute delay)

RCE (ASX) Chart

Look at the upside... more tests mean more news flow... & that s...

Red Mountain Mining: record gold prices, two projects, two greenstone belts

As Nvidia cools, we're looking to Aussie AI

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

CBA breaks trading record on strong day for Aussie financials

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Shekel Brainweigh investor presentation webinar – the future of retail automation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Look at the upside... more tests mean more news flow... & that s...

Top Stories

Red Mountain Mining: record gold prices, two projects, two greenstone belts

As Nvidia cools, we're looking to Aussie AI

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

CBA breaks trading record on strong day for Aussie financials

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Shekel Brainweigh investor presentation webinar – the future of retail automation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News